Clinical trial
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant…
NCT00068666 · Alliance for Clinical Trials in Oncology, Other · Terminated
Key facts
| NCT number | NCT00068666 |
|---|---|
| Title | Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System |
| Official title | A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Melanoma (Skin), Metastatic Cancer |
| Intervention type | Drug, Radiation |
| Interventions | temozolomide, radiation therapy |
| Enrollment | 41 |
| Start date | Jan 1, 2004 |
| Primary completion | Mar 1, 2005 |
| Completion | Mar 1, 2010 |
| First posted | Sep 11, 2003 |
| Last update posted | Dec 15, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: